Loading...

National Research Corporation

NRCNASDAQ
Healthcare
Medical - Healthcare Information Services
$13.85
$0.19(1.39%)

National Research Corporation (NRC) Financial Performance & Income Statement Overview

Analyze National Research Corporation (NRC) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.

Revenue Growth
-3.72%
3.72%
Operating Income Growth
-12.11%
12.11%
Net Income Growth
-19.98%
19.98%
Operating Cash Flow Growth
-9.15%
9.15%
Operating Margin
19.78%
19.78%
Gross Margin
57.97%
57.97%
Net Profit Margin
12.78%
12.78%
ROE
61.34%
61.34%
ROIC
26.31%
26.31%

National Research Corporation (NRC) Income Statement & Financial Overview

View the income breakdown for National Research Corporation NRC across both annual and quarterly reports.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Net Income$5.79M$6.56M$5.69M$6.17M
Depreciation & Amortization$1.54M$1.52M$1.55M$1.51M
Deferred Income Tax$1.94M-$499000.00$90000.00$116000.00
Stock Based Compensation$171000.00$188000.00$189000.00-$57000.00
Change In Working Capital-$2.90M-$1.46M$1.89M-$951000.00
Accounts Receivables-$272000.00$5000.00-$569000.00$1.07M
Inventory$0.00$0.00$0.00$0.00
Accounts Payables$627000.00-$707000.00$566000.00$184000.00
Other Working Capital-$3.26M-$761000.00$1.89M-$2.21M
Other Non-Cash Items$113000.00$77000.00$23000.00-$56000.00
Net Cash From Operating Activities$6.65M$6.38M$9.42M$6.79M
Investments In Property Plant & Equipment-$2.99M-$4.44M-$1.60M-$5.27M
Acquisitions Net$0.00-$4.83M-$4.83M$0.00
Purchases Of Investments$0.00$0.00$0.00$0.00
Sales/Maturities Of Investments$0.00$0.00$0.00$0.00
Other Investing Activities$0.00$0.00$0.00$0.00
Net Cash Used For Investing Activities-$2.99M-$4.44M-$6.43M-$5.27M
Debt Repayment$2.51M$9.05M$11.43M$136000.00
Common Stock Issued$0.00$0.00$0.00$0.00
Common Stock Repurchased-$4.92M-$7.40M-$8.55M$0.00
Dividends Paid-$2.77M-$2.82M-$2.86M-$2.87M
Other Financing Activities-$210000.00-$5000.00$15000.00$0.00
Net Cash From Financing Activities-$5.39M-$1.16M-$17000.00-$2.73M
Effect Of Forex Changes On Cash$0.00$0.00$0.00-$1000.00
Net Change In Cash-$1.73M$772000.00$2.98M-$1.21M
Cash At End Of Period$2.50M$4.23M$3.46M$485000.00
Cash At Beginning Of Period$4.23M$3.46M$485000.00$1.70M
Operating Cash Flow$6.65M$6.38M$9.42M$6.79M
Capital Expenditure-$2.99M-$4.44M-$1.60M-$5.27M
Free Cash Flow$3.66M$1.94M$7.83M$1.52M

National Research Corporation (NRC) Cash Flow Analysis

$13.85
+1.39%

Operating within the Medical - Healthcare Information Services industry under the Healthcare sector, National Research Corporation is trading at $13.85 and currently holds a market capitalization of N/A.

Cash Flow Overview

National Research Corporation's cash flow assessment details how it manages money across operations, investments, and financing. This financial overview reflects the company's ability to fund activities, sustain growth, and respond to market conditions.

Key Cash Flow Metrics

Operating Cash Flow per Share (TTM)$1.29
Free Cash Flow per Share (TTM)$0.66
Cash per Share (TTM)$0.23
Free Cash Flow Yield (TTM)0.05%
Operating Cash Flow to Sales Ratio0.21

Financial Position Indicators

Current Ratio0.70
Working Capital$-10.61M
Debt-to-Equity Ratio3.80
Price to Free Cash Flow21.25
Enterprise Value$392.86M

Stock Performance Summary

The data below highlights National Research Corporation's results over various time intervals.

1-Day
-10.78%
5-Day
-6.92%
1-Month
-26.51%
YTD
-35.40%
52W Range
$9.76 - $23.29

Company Information

Headquarters: Lincoln, US

Employees: 368

Website:nrchealth.com

Investment Metrics

P/E Ratio (TTM)17.60
EPS (TTM)$0.77
Dividend YieldN/A
Book Value per Share$0.94
ROE (TTM)61.34%

Understanding Cash Flow Statements

Cash flow statements are crucial financial documents that track the movement of cash in and out of a business. Unlike income statements that may include non-cash items, cash flow statements focus exclusively on actual cash transactions.

Three Components of Cash Flow:

Operating Activities

Revenue-related cash flow from operations

Investing Activities

Investment-related cash outflows for acquisitions, securities, or physical assets

Financing Activities

Proceeds from debt issuance, equity funding, and dividends

Data Update: Financial data is updated regularly based on company filings. Last earnings announcement: October 24, 2025.All financial metrics are trailing twelve months (TTM) unless otherwise specified. Currency: USD. Exchange: NASDAQ.

Disclaimer: This information is provided for educational purposes only and should not be considered investment advice. Please conduct your own research and consult with financial advisors before making investment decisions.

National Research Corporation (NRC) Cash Flow Analysis

The cash flow statement reveals the National Research Corporation (NRC) liquidity trends, with operating cash flow per share at $1.29, reflecting core business performance. Investing activity changes were 8.25%, indicating capital expenditures or asset sales, while financing activity shifted by 60.91%, showing debt or equity movements. Free cash flow per share was $0.66, highlighting funds available for growth or shareholder returns. Year-over-year change in operating cash flow is -9.15%, demonstrating financial health shifts. For deeper insights, compare these figures with income statements and balance sheets to assess sustainability and strategic priorities.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;